Related Experiment Videos
Human airway epithelia express a beta-defensin
1Department of Pediatrics, University of Iowa College of Medicine, Iowa City 52242, USA.
Summary
Human airway surface fluid has antimicrobial properties. Researchers identified human beta-defensin-1 (hBD-1) in airway epithelia, suggesting its role in lung defense against bacteria.
Area of Science:
- Pulmonary Medicine
- Microbiology
- Immunology
Background:
- Human airway surface fluid exhibits antimicrobial activity.
- Defensins, cationic peptides with broad-spectrum antimicrobial properties, are potential candidates for this activity.
- While found in other species' airway epithelia, defensins had not been isolated from human airway epithelia.
Purpose of the Study:
- To identify antimicrobial factors in human airway surface fluid.
- To clone and characterize human beta-defensin-1 (hBD-1) from human airway epithelia.
- To investigate the expression and localization of hBD-1 in the human lung.
Main Methods:
- Cloning of the full-length coding sequence for hBD-1 from human airway epithelia.
- Sequence homology analysis comparing hBD-1 to other beta-defensins.
- Northern blot analysis to detect hBD-1 transcripts in airway epithelia.
- Ribonuclease protection assay to determine transcript abundance and distribution in the lung.
Main Results:
- The full-length coding sequence for hBD-1 was successfully cloned from human airway epithelia.
- hBD-1 shares sequence homology with known antimicrobial beta-defensins.
- A single hBD-1 transcript was detected in airway epithelia, with higher abundance in conducting airways compared to gas exchange regions.
- hBD-1 expression was found to be developmentally regulated.
Conclusions:
- Human beta-defensin-1 (hBD-1) is present in human airway epithelia.
- hBD-1 likely contributes to the antimicrobial activity of airway surface fluid.
- hBD-1 plays a role in the innate mucosal defense mechanisms of the human lung.